Aryl-hydrocarbon receptor in smooth muscle cells protect against dioxin induced adverse remodeling of atherosclerosis

|

|

Summary

This summary is machine-generated.

Environmental dioxin exposure accelerates atherosclerosis by modulating smooth muscle cells (SMC). The Aryl-hydrocarbon receptor (AHR) in SMCs protects against dioxin

Area Of Science

  • Cardiovascular Research
  • Environmental Toxicology
  • Cell Biology

Background

  • Environmental dioxin exposure is linked to increased myocardial infarction risk.
  • Smooth muscle cells (SMC) play a key role in atherosclerotic plaque remodeling.
  • The precise mechanisms of dioxin's adverse effects on SMCs remain unclear.

Purpose Of The Study

  • To elucidate the molecular mechanisms by which dioxin exposure modulates SMCs in atherosclerosis.
  • To investigate the role of the Aryl-hydrocarbon receptor (AHR) in dioxin-induced SMC dysfunction.
  • To determine how dioxin impacts atherosclerotic plaque development and stability.

Main Methods

  • Single-cell RNA and ATAC sequencing on mouse aorta and primary human coronary artery SMCs exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD).
  • Histological analyses, functional phenotypic assays, and ChIP-Sequencing for AHR and TCF21.
  • SMC-specific <i>Ahr</i> knockout mouse models were utilized.

Main Results

  • Dioxin exposure modulated SMCs, accelerating atherosclerosis by increasing lesion size, SMC migration, and macrophage recruitment.
  • <i>C3</i>-expressing modulated SMCs were associated with increased inflammation.
  • TCDD treatment altered gene expression and chromatin accessibility, enriching for AHR binding and decreasing TCF21 occupancy.
  • SMC-specific <i>Ahr</i> knockout exacerbated dioxin-induced plaque vulnerability, oxidative stress, and macrophage infiltration.

Conclusions

  • Dioxin adversely remodels atherosclerotic plaques by promoting SMC phenotypic modulation, inflammation, and oxidative stress.
  • TCF21 occupancy may be a key factor in dioxin's adverse effects on SMC phenotype.
  • AHR signaling in SMCs confers protection against dioxin-induced atherosclerosis by stabilizing plaque phenotype and reducing oxidative stress.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers 01:30

590

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

Transducer Mechanism: Nuclear Receptors 01:31

1.3K

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

...

Adrenergic Receptors: ɑ Subtype 01:31

1.4K

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System 01:26

386

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Antihypertensive Drugs: Action of Calcium Channel Blockers 01:18

459

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...